Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to PHAT. [ FAQ on what and how to ask] For non-PHAT questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 100 Campus Drive, Suite 102, Florham Park, NJ, United States, 07932
Employees: 371
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
CEO, President & Director
Co-Founder
Co-Founder
Chief Financial & Business Officer
Chief Legal Officer & Corporate Secretary
Senior VP and Head of Sales, Operations & Training
VP of Finance & Principal Accounting Officer
Director of Business Development & Investor Relations
Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer
Senior Vice President of Marketing & Analytics
My Watchlist
